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Abstract.  The gastrointestinal  tract is lined with a 
monolayer of cells that undergo perpetual and rapid 
renewal.  Four principal,  terminally  differentiated cell 
types populate the monolayer, enterocytes, goblet 
cells, Paneth cells, and enteroendocrine cells.  This ep- 
ithelium exhibits complex patterns of regional differen- 
tiation,  both from crypt-to-villus and from duodenum- 
to-colon.  The "liver" fatty acid binding protein 
(L-FABP) gene represents a useful model for analyz- 
ing the molecular basis for intestinal epithelial 
differentiation since it exhibits cell-specific, region- 
specific, as well as developmental stage specific ex- 
pression. We have previously linked portions of the 5' 
nontranscribed domain of the rat L-FABP gene to the 
human growth hormone (hGH) gene and analyzed ex- 
pression of the fusion gene in adult transgenic mice. 
High levels of hGH expression were noted in entero- 
cytes as well as cells that histologically resembled 
enteroendocrine cells. In the present study, we have 
used immunocytochemical techniques to map the dis- 
tribution of enteroendocrine cells in the normal adult 
mouse gut and to characterize those that synthesize 
L-FABP.  In.addition,  L-FABP/hGH fusion genes were 
used to identify subsets of enteroendocrine cells based 
on their ability to support hGH synthesis in several 
different pedigrees of transgenic  mice. The results i'e- 
veal remarkable differences in transgene expression be- 
tween, and within,  enteroendocrine cell populations 
previously classified only on the basis of their neu- 
roendocrine products.  In some cases, these differences 
are related to the position occupied by cells along the 
duodenal-to-colonic and crypt-to-villus axes of the gut. 
Thus,  transgenes appear to be sensitive tools for ex- 
amining the cellular and regional differentiation of this 
class of intestinal  epithelial cells. 
T  H  E mouse intestine is lined with a complex monolayer 
composed of a number of distinct, differentiated  cell 
types. The four principal ones are polarized, absorp- 
tive enterocytes, goblet cells, Paneth cells, and enteroendo- 
crine cells.  Tritiated  thymidine  labeling  studies  as well as 
histochemical analyses of normal and chimeric mouse intes- 
tine indicate that these terminally  differentiated  cells arise 
from pluripotent stem cells (2, 9). In adult mice, each intesti- 
nal crypt contains a population of stem cells located near its 
base that are derived from a single progenitor (9). Descen- 
dants of these crypt stem cells differentiate during a well or- 
ganized,  rapid,  and bipolar migration  process (15). Cell- 
specific  and region-specific  differences in gene expression 
are established and maintained in this continuously prolifer- 
ating and differentiating gut epithelium.  Regional "differenti- 
ation" occurs in several dimensions:  from the crypts of Lie- 
berkiihn  to the villus tip and from the proximal  duodenum 
to the colon. The enteroendocrine population  provides the 
most dramatic illustration  of this point.  A large number of 
enteroendocrine cell types have been identified in the intesti- 
nal epithelium based on their geographic location,  their neu- 
rosecretory granular morphology,  and their neurohormonal 
content (3, 6,  10,  18). 
Recent studies have shown that transgenic  mice represent 
a useful tool for exploring  the mechanisms  responsible for 
regulating  region-specific,  cell-specific  and developmental 
stage-specific expression of genes in the intestine (5, 14, 20, 
22). The mouse "liver" fatty acid binding protein (L-FABP)  ~ 
gene is efficiently expressed in hepatocytes, enterocytes, and 
in some cells that histologically resemble enteroendocrine 
cells (22).  Marked differences  in L-FABP mRNA and pro- 
tein accumulation  occur along the crypt-to-villus and duode- 
nal-to-colonic  axes of the gut (20, 22). Functional  mapping 
studies of the 5' nontranscribed region of the L-FABP gene 
using transgenic mice have shown that distinct cis-acting  ele- 
ments, including orientation independent  suppressor(s), are 
necessary for maintaining  appropriate duodenal-to-colonic 
differences  in its expression.  However, these elements  are 
1. The proper designation for the mouse liver fatty acid binding protein gene 
isfabpl (see reference 21).  For convenience, in this and previous publica- 
tions (20,  22), we have used L-FABP when referring to the gene and its 
mRNA and protein products. 
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tribution of L-FABP,  at least in enterocytes (22). In this re- 
port,  we have  conducted a  series of immunocytochemical 
analyses to extend these L-FABP promoter mapping studies 
to enteroendocrine cells. In so doing, we have identified a 
previously undefined  level of differentiation  within the gut 
epithelium,  based on the ability of cellular populations to 
support  expression of L-FABP-containing  transgenes. 
Materials and Methods 
Tmnsgenic Mice 
Several pedigrees of transgenic mice were used for these studies. Some con- 
tained nucleotides  -4,000 to +21 of the rat L-FABP gene (22) linked to 
the hGH gena (17) beginning  at its nncleotide +3 (5, 20, 22). Mice heterozy- 
gous for this transgene were derived from two founders ((3ol and ¢3o46 in 
refi,  rence 22). The other pedigrees contained nucleotides  -596 to +21 of 
the rat L-FABP gene linked to human growth hormone (hGH)  2. Obligate 
heterozygotes for this transgeue were obtained from founders 13 and 19 in 
reference 22. Mice were fed a standard chow diet ad libitum and maintained 
under strictly cycled lighting conditions (lights on between 0600-1800 h). 
They were killed at 4-6 mo of age by cervical dislocation.  Their tissues 
were rapidly dissected and then fixed in Bouin's solution (22). 
lmmunocytochemical Methods 
5-~m-thick sections were cut from regions of the intestine that had been 
embedded in paraffin.  Sections were subsequently treated with xylene to 
remove the paraffin,  rehydrated in graded ethanols, and preincubated for 
30-rain in PBS containing 0.2% nonfat powdered milk, 2% BSA, and 0.3% 
Triton X-100. Primary antisera were diluted in the same buffer and applied 
to the sections.  Sections were incubated overnight at 40C, washed in PBS, 
and then incubated for 1 h with gold labeled goat anti-rabbit serum. After 
washes in PBS and H20, silver enhancement solution was added according 
to the manufacturer's protocol (Jannsen Life Sciences Products, Piscataway, 
NJ). Silver precipitation was monitored under the light microscope.  Sec- 
tions were subsequently  bathed in H20 and lightly counterstained with he- 
matoxylin. 
A panel of antisera were used to survey the enteroendocrine population 
of the intestine.  Their origins and final dilution were as follows:  rabbit 
anti-L-FABP (I:ID00; reference 22), goat anti-hGH (1:1,000; reference 8), 
rabbit anti-hGH (1:1,000; Dako Corp., Santa Barbara, CA), rabbit or goat 
antiserotouin (1:3,200,  1:600;  lncstar Corp., Stillwater,  MN), rabbit an- 
ti-/~-endorphin  (1:400, reference 4),  rabbit antidynorphin (residues  1-8) 
(1:400;  reference  12),  rabbit anti-met-enkephalin (1:400;  reference  13), 
rabbit antineurotensin (1:200;  !ncstar), rabbit anticholecystokinin  (CCK) 
(residues  1-39) (1:800; Peninsula Laboratories, Inc., Belmont, CA), rabbit 
anti-glncagon-like peptide  1 (GLP-I)  (residues  1-19) (1:400;  Peninsula 
Laboratories, Inc.), rabbit antignstric inhibitory peptide (GIP) (1:400, Pen- 
insula Laboratories, Inc.), rabbit antiseeretin (1:400; Peninsula Laborato- 
ries, Inc.), rabbit  antisomatostatin  (1:200; lncstar), rabbit antivasonctive in- 
testinni peptide (1:200; Incstar), rabbit antigastrin releasing peptide (1:400; 
reference 11), rabbit  anti-galanin  (1:400; Peninsula Laboratories, Inc.), rab- 
bit antineuropeptide  tyrosine (NPY) (1:400, Peninsula Laboratories, Inc.), 
rabbit antipeptide histidiue isoleucine (PHI) (1:400, Dako Corp.), and rab- 
bit antipancreatic  polypeptide (PP) (1:400; Dako Corp.). The immunostain- 
ing characteristics  and unique specifieities of the L-FABP and hGH antisera 
have been demonstrated in previous reports (22, 23). The specificity of the 
remaining antisera was verified using sections prepared from tissues con- 
taining cells known to support synthesis of the relevant antigen and by the 
use of nonimmnne rabbit and goat sent. Note that in control experiments, 
no hGH immunoreactivity was found in normal mouse intestine,  demon- 
strating that the hGH antisera did not cross-react with any of the neumendo- 
crine peptides present in enteroendocrine cells. 
To quantitate expression of neuroendocrine products in the enteroendo- 
criue cells of transgenic mice and their normal littermates, from 6 to 16 
cross sections of the intestine were' examined from duodenum, proximal 
2. Abbreviations used in this paper: CCK, cholecystokinin; GIP, gastric in- 
hibitory peptide; GLP, glucagon-like  peptide; hGH, human growth; NPY, 
neuropeptide tyrosina; PHI, peptide histidine isoleucine;  PP,  pancreatic 
polypeptide. 
jejunum, distal jejunum, ileum, plus the proximal and distal halves of the 
colon (see reference 22 for a description of how these regions were opera- 
tionally defined). The total number of positive cells/complete  cross section 
was counted. Moreover,  each positive cell was classified  as being either 
crypt or villus associated.  As emphasized in Results, no qualitative or quan- 
titative differences  in the distribution of any endogenous neuroandocrine 
product was found between animals in any of the four transgenic pedigrees 
and between transgenic animals and their normal littermnte~. Therefore, 
results from all animals were averaged for each segment of the proximal to 
distal axis surveyed. 
Double Labeling: Simultaneous  lramunofluorescence 
Double label immunofluorescence  studies  were performed on individual 
sections by coincubation of primary antisera raised in two different species: 
rabbit and goat. Two separate secondary antisera raised in donkeys against 
rabbit and goat immunoglobulin were used to detect the two primary an- 
tisera. These secondary  antibodies were labeled with either fluorescein or 
Texas red (Jackson Immunoresearch Laboratories, West Grove, PA). After 
an overnight incubation at 4"C with the two primary antisera, sections were 
washed in PBS, and then incubated for I h at room temperature with donkey 
anti-rabbit and donkey anti-goat-labeled sera diluted 1:160. Tissue sections 
were subsequently  washed with PBS, mounted with PBS/glycerol (1:1) and 
examined under the fluorescence microscope using filters of the appropriate 
wavelength. Note that control studies showed no cross-reactivity  between 
mismatched  primary and secondary antisera. 
Double Labeling: Sequential Immunogoid 
Silver/lmmunofluorescence Staining 
We used sequential ~mmunogold silver staining and fluorescence  micros- 
copy to label two separate antigens in a single tissue section when the only 
available antisera were raised in a single species (rabbit). Sections were first 
immunostained for a particular antigen using the immunogold silver stain- 
ing method described above. This was followed by application of the second 
primary antiserum and then a fluorescent-labeled  second antiserum. As pre- 
viously reported by Scopsi and Larsson (16), we found that the immunogeld 
silver staining method did not interfere with subsequent immunofluores- 
cence staining. Most importantly, we found that deposition of silver a.mund 
the  first  primary antiserum-gold labeled secondary antiserum complex 
abolished its immunoreactivity.  This phenomena is similar to the masking 
of immunoreactivity by DAB tetrabydrochloride in the unlabeled antibody 
pamxidase-antipemxidase method (19). This "masking" of the first rabbit 
primary antiserum by silver deposition allowed us to add a second rabbit 
primary antiserum to the section that could then be visualized  by adding 
flnorescent-labeled  anti-rabbit secondary antibodies. The specificity of this 
procedure was verified in control studies by substituting  normal rabbit se- 
rum for either  one, or both, of the primary rabbit  antisera. When both rabbit 
and goat antiserum were available, we compared the results obtained using 
this sequential immunogold/immunolluoreseence  method with the results of 
the double label immunoflnorescence  procedure described in the preceding 
paragraph. Both double labeling procedures produced identical results. In 
other control experiments,  we found that deposition of silver around the first 
primary antiserum-gold labeled secondary antiserum complex destroyed its 
subsequent antigenicity without precluding colocalization of a second anti- 
gen to the silver stained cell. Thus, this procedure could easily demonstrate 
colocalization  of two antigens in a single cell. 
Triple Labeling: Sequential  lmmunogold Silver/ 
Simultaneous Immunofluorescence Staining 
A logical  next step was to perform double labeling immunotluorescence 
studies on sections previously  stained by the immunogold  silver method. 
This allows localization of three antigens in a single tissue section by using 
two antisera raised in one species and a third antiserum produced in a differ- 
ent species.  The immunogold silver staining method is performed first. As 
described above, deposition of silver around the primary rabbit antiserum- 
gold labeled goat anti-rabbit serum complex destroys the antigenicity of the 
primary antiserum. In addition, the antigenicity of the goat anti-rabbit  sec- 
ondary serum is also effectively masked.  After silver deposition, sections 
are processed  for double label simultaneous immunofluoreseence.  Control 
experiments using sections previously  stained with primary rabbit antise- 
rum and the immunogeld-silver  detection method showed that the sequen- 
tial addition of normal rabbit serum and/or normal goat serum followed by 
Texas red-labeled donkey anti-rabbit serum and fluorescein-labeled  donkey 
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gold-silver staining. 
Results 
Description of Transgenic Mice Used 
to Map Enteroendocrine Populations in the 
Small and Large Intestine 
We previously noted (22) that the intact, endogenous mouse 
L-FABP gene (fabp/) is expressed at highest levels in the 
proximal jejunum of adult mice. The steady-state concentra- 
tions of its mRNA and protein products steadily decline as 
one proceeds to the distal ileum. These gene products are not 
detectable in the colon. Within the small intestine, L-FABP 
is not expressed until epithelial cells emerge from the crypts 
of Lieberkiihn. Functional mapping studies of the rat L-FABP 
promoter  in transgenic mice revealed that cis-acting ele- 
ments contained between nucleotides  -596  and  +21  are 
sufficient to produce a pattern of reporter gene (hGH) ex- 
pression  that  recapitulates  the  duodenal-to-ileal  gradient 
noted with the intact, endogenous mouse L-FABP gene (22). 
However, they are not sufficient to prohibit hGH expression 
in the crypts of Lieberkiihn nor to repress its synthesis in the 
colon. Addition of nucleotides  -597  to  -4,000  in either 
orientation "restores" an appropriate proximal-to-distal pat- 
tern of hGH accumulation by suppressing colonic expres- 
sion, but these additional sequences do not prevent its "anom- 
alous" accumulation in the crypts of Lieberkiihn (22). Up to 
several hundred copies of either transgene/haploid gem)me 
have no effect on the cell-specific or regional patterns of ex- 
pression of the endogenous mouse L-FABP gene, suggesting 
that the trans-acting factors that are responsible for regulat- 
ing its expression are present in high concentrations within 
intestinal epithelial cells. 
We initiated an analysis of transgene expression in the 
enteroendocrine population of transgenic mice containing 
either  one  of  these  two  L-FABP/hGH  transgenes:  i.e., 
L_FABP-4.000 ~o +2~/hGH or L-FABP  -Ss~ ~ +2~/hGH. Animals 
from four different pedigrees were analyzed (two pedigrees/ 
transgene). In this way, we could assess whether cellular pat- 
terns ofhGH expression were influenced  by the site of inser- 
tion of  these L-FABPIhGH fusion genes. The enteroendocrine 
population was selected for these studies for two reasons. 
First, it is remarkably complex with approximately 15 differ- 
ent subtypes, some of which exhibit dramatic geographic 
differences in their distribution along the crypt-to-villus and 
duodenal-to-colonic axes of the gut (3, 6,  10,  18). Second, 
we had previously noted (22) that while L-FABP immum)- 
reactivity is primarily limited to small intestinal villus-as- 
sociated  enterocytes  (Fig.  1 A),  rare,  intensely  staining 
(L-FABP positive) cells with the histologic appearance of  en- 
teroendocrine cells are present in duodenal villi. The nature 
of this enteroendocrine cell population had not been defined 
in these earlier studies. Other than enterocytes and these rare 
enteroendocrine appearing cells, the L-FABP gene is quite 
restricted in  its expression:  L-FABP is not detectable in 
Paneth cells or in goblet cells by light microscopic immum)- 
cytochemistry using  either  the peroxidase  antiperoxidase 
staining method (22)  or the more sensitive immunogold- 
silver enhancement technique (data not shown). Moreover, 
no immunoreactive L-FABP can be detected by immuno- 
gold-silver staining in either colonic or stomach epithelium. 
The Regional Distribution of  Enteroendocrine Cells 
in the Mouse Gut 
Since there was little information available about the peptide 
content of enteroendocrine cells in the mouse (10, 25), we 
first conducted a survey of  enteroendocrine cell types present 
in normal adult C57BL/6J  x  LT/SV mice and their trans- 
genic littermates.  Sixteen different antisera were used for 
this analysis. Enteroendocrine cells were stained with anti- 
sera directed against serotonin, GIP, CCK, secretin, GLP-I, 
PP, NPY,  somatostatin, and neurotensin. Galanin, vasoac- 
tive intestinal peptide, PHI, met-enkephalin, gastrin releas- 
ing peptide/bombesin, ~endorphin, and dynorphin antisera 
failed to stain enteroendocrine cells although enteric nerves 
were frequently positive (data not shown). 
Serotonin containing enterochromaflin cells represent the 
largest population of enteroendocrine cells in this strain of 
mice (Fig.  1 B).  These cells are  found in high numbers 
throughout the length of the intestine and are present in both 
crypts and villi (Table I).  CCK (Fig.  1 C) and GIP im- 
mure)reactive cells are both found in highest concentration 
in  the  duodenum and  proximal jejunum.  Approximately 
25 % of each of these cell types are located in the crypts of 
Lieberkiihn (Table I). Secretin containing cells are also most 
abundant in the duodenum and proximal jejunum. However, 
unlike cells that reacted with our CCK and GIP antisera, 
secretin-immunoreactive cells are confined to villi. GLP-1 
cells have a bimodal distribution along the proximal to distal 
axis of the gut: they are found with highest frequency in the 
proximal jejunum and colon (Table  I) with only rare im- 
munoreactive cells  located in the duodenum, ileum,  and 
distal colon. GLP-1 producing cells are almost evenly dis- 
tributed between the crypt and villus. NPY and PP immuno- 
reactive cells are rare in the small intestine but are present 
in relatively high numbers in the colon (Table I and foot- 
note).  Somatostatin and neurotensin immum)reactive cells 
are present in this strain of mice but their numbers are too 
few to confidently define their geographic distribution. 
It is important to re,  emphasize (see Materials and Meth- 
ods) that the distribution of these different enteroendocrine 
cell types is not affected by the presence of multiple copies 
of either transgene: there were no qualitative or quantitative 
differences in the regionad  distribution of these enteroen- 
docrine populations between any members of the various 
L-FABP/hGH transgenic pedigrees and their normal litter- 
mates. Overall, the geography of the enteroendocrine cell 
populations in the mouse gut is similar to that reported in 
humans (3, 6,  18). 
L-FABP  Is Restricted to a Small Subset of 
Enteroendocrine Cells 
Double labeling methods were used to characterize the en- 
teroendocrine  cell  population  that  synthesizes  L-FABP. 
Since serotonin immunoreactive cells are the most abundant 
enteroendocrine cell type, we used simultaneous double la- 
bel immunofluorescence methods to initially determine if 
L-FABP is expressed in serotonin producing enteroendo- 
crine cells. In all normal (as well as transgenic) mice exam- 
ined, only rare serotonin immure)reactive cells contained 
L-FABP (Fig. 2, A-C). These cells are largely limited to villi 
located in the duodenum and proximal jejunum. They repre- 
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Proximal  Distal  Proximal  Distal 
Duodenum  Jejunum  Jejunum  Ileum  Colon  Colon 
Serotonin  72  +  9  80  +  6  40  +  3  44  +  10  120  +  12  131  +  22 
19%  19%  15%  38%  36%  32% 
CCK  20  +2  26  +  5  24  +  5  -  -  - 
39%  17%  20% 
GIP  15  +  3  22  +2  18  +4  -  -  - 
24%  21%  23% 
Secretin  17+  4  14  +  4  .... 
0%  0% 
GLP-I  -  14  +  2  13  +  3  -  22  +  2  - 
43%  23%  83% 
NPY (PYY) .....  34  +  8  48  +  4 
20%  52% 
PP  ....  21  +  3  16  +  3 
12%  38% 
hGH  85  +  7  58  +4  30+  5  -  -  - 
(-4000  to  +21)  11%  21%  21% 
hGH  97  +9  88  +  8  55  +  8  7-1-  l  53  +  5  - 
(-596  to  +21)  14%  17%  17%  16%  25% 
Distribution  of enteroendocrine cells in the adult mouse gastrointestinal  tract.  (Number of cells per cross section [g +  SEM]; percentage of cells in crypts.) To 
quantitate the expression of neuroendocrine products in enteroendocrine  cells, 6-16 complete cross sections of the intestine were examined from each of the indicat- 
ed regions. The number of immunoreactive  cells per complete cross section were counted and the results averaged.  The location of each immunoreactive  cell in 
either crypt or villus was noted. The percentage of immunoreactive  enteroendocrine cells found in the crypts is presented below the mean of the total number 
of cells per section. A dash indicates  that only rare positive cells (<10 cells/cross section) were found in this gut segment. Neurotensin and somatostatin  im- 
munoreactive  cells were found too infrequently  for precise qunatitation. 
* The peptide species that react with these two antisera have not been definitively established.  Antisera raised against PP and NPY frequently show cross-reactivity 
with the structurally  related  peptide tyrosine tyrosine (PYY) (7). 
sent <5 % of the serotonin immunoreactive cells in these 
regions. 
The antisera we had available against L-FABP and the 
other  peptide  products  of enteroendocrine cells  were all 
raised in rabbits. We therefore used the sequential immuno- 
gold silver-immunofluorescence technique described in Ma- 
terials and Methods to determine if other, nonserotonergic 
enteroendocrine cells synthesize L-FABP. We validated this 
method by incubating sections of intestine with rabbit anti- 
L-FABP serum followed by rabbit anti-serotonin serum. The 
resulting patterns of cellular staining were identical to those 
obtained with the simultaneous double label immunofluores- 
cence technique described above that used goat antiserotonin 
(compare Fig. 2, A-C, to Fig. 2, D-F, and to Fig. 5, E-H). 
There was a striking lack of L-FABP coexpression in the 
other enteroendocrine cell populations surveyed including 
those which synthesize CCK, GIP, secretin, and GLP-1. Fig. 
2, G-l, demonstrates the ~ypical" result: fluorescently la- 
beled enteroendocrine cells produce a "blank" signal in the 
L-FABP immunogold-silver-stained sections. (This lack of 
coexpression was not an artifact of silver deposition into 
L-FABP producing cells that somehow precluded localiza- 
tion of a second antigen to the "blocked" cell. As noted be- 
low, colocalization of other antigen combinations could eas- 
ily be demonstrated using the same sequential immunogold 
silver/immunofluorescence method.) 
We concluded that the L-FABP positive enteroendocrine 
cells first noted in our earlier study of normal and transgenic 
mouse intestine (22), represented a small subpopulation of 
serotonergic cells and that few, if any, nonserotonergic en- 
teroendocrine cells contain high concentrations of immuno- 
reactive L-FABP.  Thus,  L-FABP immunoreactivity subdi- 
vides the enterochromafiin cell population into two distinct 
subsets. The function of L-FABP in this small subpopulation 
of enterochromaffin cells is unclear although it could be in- 
volved in mediating the effects of luminal contents (i.e., long 
chain fatty acids) on synthesis and/or release of their basal 
granular contents. 
Distribution of hGH Positive Enteroendocrine Cells in 
Mice Containing L-FABP/hGH Transgenes: Lack of 
Coexpression of  L-FABP and hGH 
Two patterns of cellular staining for hGH were noted in the 
Figure 1.  Immunoreactive cell populations in the mouse gastrointestinal tract. A-C are from normal adult C57BL/tJ  ×  LT/SV mice. D 
is  from  a  L-FABP  -~°° to +21/hGH  transgenic mouse.  L-FABP immunoreactivity  (.4)  is  found  primarily  in  villus enterocytes; "empty" 
L-FABP negative goblet and enteroendocrine cells are scattered between the positive villus enterocytes. Enteroendocrine cells are clearly 
labeled with antisera directed against serotonin (B) or specific peptide products (e.g., CCK in C). In transgenic mice containing L-FABP/ 
hGH fusion genes, two patterns of hGH immunoreactivity are seen in gut epithelial cells. An intense "Golgi-like" pattern of staining is 
present in enterocytes while a  second class of cells, histologically resembling enteroendocrine cells, contain strong, diffuse cytoplasmic 
staining often with prominent basally oriented granular  staining (D).  Bar,  25 #m. 
Roth et al. Enteroendocrine Cell Populations in Transgenic Mice  1795 Figure 2.  Use of multiple label immunocytochemical methods to characterize  L-FABP containing enteroendocrine cells.  In each set of 
panels the arrow identifies the enteroendocrine  cell of interest. A-C show an L-FABP-S96t°+2~/hGH  transgenic mouse. (.4) Section of prox- 
imal jejunum stained with goat antiserotonin and rabbit anti-L-FABP antisera.  The primary goat serum was visualized with fluorescein- 
labeled donkey anti-goat serum and the primaryrabbit  serum with Texas red-labeled donkey anti-rabbit  serum. The immunoreactive  sero- 
tonin cell seen in A corresponds to the ceil that was not labeled with L-FABP antiserum in B. Double exposure of the section in C clearly 
demonstrates the lack of serotonin/L-FABP  coexpression.  D--F show an L-FABP  -4z°°  to +2~/hGH transgenic mouse: the lack of serotonin/ 
L-FABP coexpression can also be demonstrated by sequential immunogold  silver and immunofluorescence staining techniques. This section 
of proximal jejunum  was first incubated with rabbit anti-L-FABP  serum followed by gold-labeled goat anti-rabbit  serum and silver develop- 
ment (D). Goat antiserotonin  serum was subsequently  applied to the section and visualized with fluorescein-labeled donkey anti-goat serum 
(E). Note that the silver development completely masks the antigenicity  of the rabbit primary antiserum-goat  secondary antiserum complex. 
Double exposure of the section shows that the serotonin immunoreactive cell corresponds to an L-FABP negative enteroendocrine cell 
(F). Identical results are obtained if rabbit antiserotonin serum and Texas red-labeled donkey anti-rabbit serum are substituted for goat 
antiserotonin serum and fluorescein-labeled  donkey anti-goat serum (see Fig. 5, E-H). (G-I) The lack of enteroendocrine celI/L-FABP 
colocalization is demonstrated here for CCK cells in a normal littermate.  A single section of proximal jejunum was first stained with 
immunogold-silver for L-FABP  immunoreactivity (G) followed by rabbit anti-CCK serum and Texas red-labeled donkey  anti-rabbit 
serum (H). The CCK immunoreactive cell corresponds  to an L-FABP negative cell (I). J-L show a section of proximal jejunum from 
a L-FABP  -s~'°  +2, transgenic mouse stained for L-FABP immunoreactivity using immunogold silver staining (J) followed by goat anti- 
hGH serum detected by fluorescein-labeled  donkey anti-goat serum (K). The cell containing diffuse cytoplasmic  hGH immunoreactivity 
corresponds to a L-FABP negative cell (L). Bar, 25/~m. 
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Figure 3.  Regional distribution of hGH colocalization in enteroen- 
docrine cell subpopulations of transgenic mice. For each neuroen- 
docrine product examined, the percentage of immunoreactive  cells 
containing colocalized hGH immunoreactivity  was determined for 
both  sets of transgenic mice  in  all  gut  segments containing 
significant numbers of immunoreactive cells (>10 cells/cross sec- 
tion). At least one complete cross section from each of two animals 
from the transgenic mice pedigrees containing nucleotides -4,000 
to +21 and nucleotides -596 to +21 of the rat L-FABP  gene were 
examined. D, duodenum; PJ, proximal jejunum; D  J, distal jeju- 
num; L ileum; PC, proximal colon; DC, distal colon. 
intestinal epithelium of transgenic mice when viewed by light 
microscopic teclmiques. 3 The antisera produced strong sig- 
nals in the Golgi apparatus of enterocytes while cells with 
the histologic appearance of enteroendocrine cells had in- 
tense cytoplasmic staining (Fig. 1 D). In mice containing the 
rat L-FABP  -59~ to +2,/hGH transgene, large numbers of hGH 
containing enteroendocrine cells were found in the duode- 
num and proximal jejunum (up to 100 cells/complete cross 
section). Their numbers progressively declined in the distal 
jejunum and ileum (see Table I). However, numerous hGH 
immunoreactive enteroendocrine cells appeared in the prox- 
imal colon (53 cells/cross section compared to 7 cells/cross 
section in the ileum). <5 cells were encountered per cross 
section in the distal half of the colon. The percentage of 
hGH-containing enteroendocrine cells in crypts was similar 
from the proximal to distal intestine (14-25 %; see Table I). 
Mice heterozygous for the L-FABP  -4,~° to +2,/hGH transgene 
showed a more restricted distribution of hGH immunoreac- 
3. Recent EM immunocytochemical studies of transgenic mice containing 
the L-FABP  -59e to +21/hGH  transgene demonstrated hGH in the apical se- 
cretory granules of exocrine Paneth cells, intermediate cells, and granular 
(but not typical) goblet cells (24). This cellular pattern of hGH accumula- 
tion was  not  appreciated  using  light microscopic  immunocytochemical 
methods (22). 
tire enteroendocrine ceils along the proximal-to-distal axis 
of the gut: they had fewer hGH immunoreactive cells in the 
distal jejunum and ileum and none in their colon. These 
proximal-to-distal differences in the distribution of hGH 
containing enteroendocrine cells between the different types 
of transgenic mice were not the result of insertion site ef- 
fects:  each of the two pedigrees surveyed containing the 
L-FABP  -4.~ "+2'/hGH (or L-FABP  -s~ w  ÷21/hGH  ) transgene 
had similar distributions of hGH imm~oreactive cells. In- 
terestingly, the percentage of hGH immunoreactive entero- 
endocrine cells along the crypt-to-villus axis was similar in 
both sets of transgenic mice (Table I). 
There was virtually no overlap between hGH positive im- 
munoreactive enteroendocrine cells and L-FABP immuno- 
reactive cells in any member of any of the four pedigrees of 
transgenic mice surveyed (Fig. 2, J-L). This lack of colocal- 
ization was evident throughout the entire gastrointestinal  tract 
(i.e., from duodenum to colon) and did not reflect a change 
in the total number or distribution of L-FABP-positive en- 
teroendocrine cells in transgenic animals. These observa- 
tions suggest that cis-actiog elements in addition to those 
contained between  nucleotides  -4,000  and  +21  are  re- 
quired to restrict expression of the reporter (hGH) to the ap- 
propriate small subpopulation of enteroendocrine cells that 
normally transcribe the intact, endogenous mouse L-FABP 
gene. 
Mapping Subtle Differences within Enteroendocrine 
Cell Populations Using lhmsgenes 
The data presented above suggested that transgene expres- 
sion might represent a  new way of operationally defining 
different subpopulations of enteroendocrine cells in the in- 
testine. Double labeling simultaneous immunofluorescence 
studies were therefore performed on mice containing the 
L-FABP  -~ *~ +21/h(]H and L-FABP  -4,~ ~' +21/hGH transgenes 
using goat anti-hGH serum together with our panel of rabbit 
antisera  prepared  against the  various peptide and amine 
products of enteroendocrine cells. The percentage of each 
enteroendocrine cell type that supported synthesis of hGH 
was determined and their location in the duodenal-to-colonic 
and crypt-to-villus axes of  the intestine noted. The results are 
tabulated in Fig. 3 and illustrated in Figs. 4 and 5. 
Serotonin 
In mice containing either one of  the transgenes, ",,30% of  the 
serotonin immunoreactive cells in the duodenum contained 
hGH (Fig. 4 G). These serotonin/hGH cells were found pri- 
marily along villi although occasional double-labeled cells 
were seen in crypts. The percentage of serotonin immuno- 
reactive cells with colocalized hGH declined sharply along 
the length of the small intestine with virtually no overlap 
present in serotonin cells located in the distal jejunum, il- 
eum, and colon (Fig. 3 and Fig. 4, H-l). 
CCK 
In transgenic  pedigrees containing the L-FABP  -~ ~ ÷2'paGH 
transgene,  hGH was present in >95 %  of CCK immuno- 
reactive enteroendocrine cells. These double labeled cells 
were found in both crypts and villi.  Mice containing the 
L_FABp-4.~ to +21/hGH transgene also had a high percent- 
age (,,070%) of hGH expression in their duodenal and prox- 
Roth et al. Enteroendocrine Cell Populations in Transgenic Mice  1797 l~gure 4. Transgene expression in enteroendocrine cell subpopulations. Multilabeling studies were performed on individual sections using 
simultaneous immunofluorescence (A-l) and/or sequential immunogold silver/immunofluorescence staining (J-L). (A-C) Section of distal 
jejunum from a L-FABP  -596 to +21/hGH transgenic mouse. The section was coincubated with rabbit anti-GIP serum and goat anti-hGH se- 
rum followed by Texas red-labeled donkey anti-rabbit and ffuorescein-labeled donkey anti-goat sera. The red GIP immunoreactive cell 
in A corresponds to the diffusely stained green hGH immunoreactive cell shown in B. Double exposure of the GIP and hGH immunostained 
section shows the dOuble labeled cell as yellow (C). (D-F) Double labeling of CCK and hGH immanoreactivity in the duodenum (D), 
proximal jejunum (E), and distal jejunum (F) of a L-FABP  -4a°° to +2~/hGH transgenic mouse. CCK immunoreactive cells without hGH 
appear red (E, closed arrow) while those that coexpress hGH immunoreactivity appear yellow (E, open arrow). The percentage of CCK 
immunoreactive cells, which also contain hGH immunoreactivity, decreases along the proximal-to-distal  axis of the intestine. In contrast 
to mice with this type of transgene, mice that contain nucleotides -596 to  +21  of the rat L-FABP gene linked to hGH had near total 
overlap of hGH with CCK throughout the small intestine (see Table I). (G-l) Double staining for hGH and serotunin immunoreactivity 
in the duodenum (G), distal jejunum (H), and proximal colon (I) of a L-FABP  -4~° to +2t/hGH transgenic mouse. About 30% of the sero- 
tonin immunoreactive cells in the duodenum contained coexpressed hGH immunoreactivity, seen here as a double labeled "yellow cell" 
in G. There was a striking lack of serotonin/hGH overlap in the remainder of the gastrointestinal tract. Note the lack of overlap in H and 
lbetween red serotonin immunoreactive cells and green hGH immunoreactive cells. (J-L) Sequential staining of  a proximal  jejunum section 
from a L-FABP-4~°'°+2~/hGH transgenic mouse using rabbit anti-CCK and rabbit anti-human growth hormone sera. Sections were first 
incubated with rabbit anti-hGH serum followed by gold-labeled goat anti-rabbit serum and silver development. An intensely labeled hGH 
immunoreactive cell is seen in J. Sections were subsequently incubated with rabbit anti-CCK and Texas red-labeled donkey anti-rabbit 
serum (K). Double exposure shows the expression of CCK and hGH immunoreactivity in a single cell (L). By comparing J-L, it's clear 
that deposition of silver around the first rabbit antiserum (hGH) does not preclude the immunolocalizatiun of a  second antigen (CCK) 
to the same cell using a  second rabbit antiserum. Bar, 25/~m. 
The Journal of Cell Biology,  Volume 110, 1990  1798 Figure 5.  Sequential  immunogold  silver/simultaneous  immunofluorescence  staining  demonstrating  L-FABP-hGH-enteroendocrine  cell 
relationships. Sections from the proximal (A-H) and distal (l-L) jejunum of a transgenic mouse containing the L-FABP  -596 to +2t/hGH fu- 
sion gene were first incubated with a rabbit primary antiserum.  Antigen-antibody  complexes were detected using the immunogold silver 
technique. This was followed by coincubation of the silver-stained section with a new primary rabbit antiserum and a primary goat antise- 
rum. These antisera were detected using fluorescein-labeled donkey anti-goat and Texas red-labeled donkey anti-rabbit sera. (A-D) Mul- 
tilabeling using rabbit anti-L-FABP (A), rabbit antisecretin  (B), and goat anti-hGH  (C) sera. The triple exposure of this section shows 
colocalization of secretin and hGH immunoreactivity  in an L-FABP negative cell (D) indicated by an arrow. A second hGH positive cell, 
indicated by an arrowhead, lacks both L-FABP and secretin immunoreactivity. (E-H) Multilabeling using rabbit anti-L-FABP (E), rabbit 
antiserotonin (F), and goat anti-hGH (G) sera. Triple exposure (H) shows a total lack of overlap between serotonin immunoreactive cells, 
indicated by arrows, an hGH immunoreactive cell,  indicated by an arrowhead,  and the L-FABP immunoreactive enterocytes seen in E. 
(l-L) Multilabeling using rabbit anti-CCK (I), rabbit antiserotonin  (J), and goat anti-hGH (K) sera. Triple exposure shows that the CCK 
and hGH immunoreactivity  is coexpressed in a cell,  indicated by an arrow, which lacks serotonin  immunoreactivity  (L). The serotonin 
immunoreactive cell indicated by the arrowhead  in J  and L lacks both CCK and hGH immunoreactivity. Bar, 25 #m. 
imal jejunal CCK enteroendocrine cells. However, the per- 
cent colocalization declined sharply as one proceeded along 
the proximal to distal axis of the small intestine, reaching a 
value of 30 % in the distal jejunum and ileum (Fig. 3 and Fig. 
4, D-F, and J-L). The decreased colocalization affected both 
villus- and crypt-associated CCK immunoreactive cells. 
Gastric Inhibitory Peptide 
Virtually all GIP immunoreactive cells were found to con- 
tain  hGH  regardless  of their  location  in  the  proximal-to- 
distal or crypt-to-villus axis of the gut or the L-FABP 5' non- 
transcribed region represented in the fusion gene (Fig. 3, and 
Fig.  4, A-C). 
Secretin 
In transgenic pedigrees containing the L-FABP  -5~ ~ +~/hGH 
transgene,  nearly all  secretin immunoreactive enteroendo- 
crine cells were also positive for hGH. Addition of nucleo- 
tides -597 to -4,000 of the rat L-FABP gene, decreased the 
percent colocalization of secretin and hGH to '~60 % in both 
the  duodenum  and proximal jejunum  (Fig.  3,  and  Fig.  5, 
A-D). Since secretin producing enteroendocrine cells are not 
found in crypts, this reduction in colocalization only affected 
villus-associated cells. 
GLP-1 
For transgenic mice with nucleotides  -596 to  +21  of the 
L-FABP gene,  nearly  100%  of the GLP-1 immunoreactive 
cells locted in the proximal jejunum contained immunoreac- 
tire hGH. Addition of nucleotides -4,000 to -597 reduced 
this number to 70% (Fig. 3). GLP-1/hGH positive cells were 
present in small intestinal crypts and villi in all pedigrees of 
transgenic mice surveyed. Since transgenic mice containing 
the additional 3.3  kb from the 5' nontranscribed domain of 
L-FABP do not express hGH in their large intestine, GLP-1 
immunoreactive cells located in their colon did not contain 
any detectable hGH. 
PP and NPY 
PP and NPY cells are largely limited to the colon (Table I). 
Therefore, we observed no colocalization of PP or NPY with 
hGH in mice containing  the L-FABP  -~.~ ,o +2~/hGH trans- 
gene. By contrast, mice containing the L-FABP  -~ ~ +2t/hGH 
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with PP and NPY in their proximal colons (Fig. 3). Colocal- 
ization was rarely encountered in PP and NPY enteroendo- 
trine cells located in the distal half of the colon. 
Somatostatin and Neurotensin 
Although there are only a few somatostatin and neurotensin 
cells noted in the mouse intestinal tract, colocalization of 
hGH immunoreactivity in neurotensin positive cells was fre- 
quently seen in all pedigrees of transgenic mice. Both hGH 
positive and negative somatatostain  immunoreactive cells 
were found in mice containing  either of the two different 
types of  transgenes. Precise quantitation was not possible be- 
cause of  the limited number of somatostatin and neurotensin 
producing enteroendocrine  cells available for scoring. 
The results of triple labeling studies further illustrate the 
interrelationships of these cell types and more specifically 
the value of using transgenes  to operationally  define sub- 
populations of enteroendocrine cells. As predicted from the 
"individuaF double label comparisons, these triple labeling 
studies directly show that L-FABP immunoreactivity is ab- 
sent in hGH positive and negative enteroendocrine cell sub- 
sets (Fig. 5, A-D and E-H). They also underscore the hetero- 
geneity between enteroendocrine cell populations as defined 
by their ability to support transgene expression (see Fig. 5, 
I-L). 
Discussion 
Our studies of hGH expression in the enteroendocrine  cell 
population of adult transgenic mice containing L-FABP/hGH 
fusion genes indicate that transgene expression represents a 
new way to define populations of  this terminally differentiated 
cell type that is different from previous methods/schemes. 
Immunocytochemical studies of  the colocalization OfhGH in 
cells that produce different neuroendocrine products reveals 
an unexpected degree of complexity in the differentiation of 
this remarkably  heterogeneous but geographically well-or- 
ganized gut epithelial cellular population. 
Our initial survey of  the geographic organization of  the en- 
teroendocrine cell population in normal adult mouse intes- 
tine indicated that each cell type (defined by its neuroendo- 
crine product) had an easily discernible regional distribution 
along the proximal to distal axis of  the gut. For example, PP- 
immunoreactive cells are essentially  limited to the colon. 
CCK and GIP producing enteroendocrine  cells are numer- 
ous in the small intestine but are rarely found in the colon. 
Within the small intestine, both CCK and GIP populations 
exhibit a sharp, decreasing gradient from proximal jejunum 
to ileum. 
Some enteroendocrine  cell types not only display differ- 
ences in their distribution from duodenum-to-colon but also 
from crypt-to-villus tip. In the proximal jejunum, nearly all 
enteroendocrine cells that produce secretin are found in villi. 
By contrast, almost half of the GLP-1 immunoreactive cells 
in this region of the small bowel are found in the crypt while 
other enteroendocrine cell types (e.g., those producing CCK 
and GIP) show an intermediate percentage distribution be- 
tween crypt and villus. 
The factors that permit a given enteroendocrine cell type 
to differentiate in the "appropriate  ~ region of the crypt-to- 
villus and duodenal-to-colonic axes of the gut are unknown. 
Maintenance of a precise geographic distribution of a given 
enteroendocrine cell type is all the more remarkable given 
the fact that the intestinal epithelium undergoes perpetual 
renewal. Although tritiated thymidine labeling studies per- 
formed by Cheng and Leblond (2) suggested that enteroen- 
docrine cells are derived  from the same multipotent stem 
cells as the other principal,  terminally  differentiated,  cell 
types of the gut epithelium,  definitive data about their lin- 
eage relationships are still lacking (e.g., see reference 9). 
Analysis of the L-FABP producing enteroendocrine  cell 
population  has provided some interesting clues about ele- 
ments that are necessary  to achieve appropriate  enteroen- 
docrine cell-specific expression. L-FABP appears to be re- 
stricted to a very small subpopulation of  serotonin producing 
enteroendocrine cells located in the duodenal and proximal 
jejunal villi.  Studies of transgenic mice indicate that while 
nucleotides -4,000 to +21 of  the L-FABP gene contain cis- 
acting  sequences  that  can direct expression  of a  reporter 
(hGH) to enterocytes, they lack those elements which limit 
L-FABP expression in enteroendocrine cells. In other words, 
distinct  cis-acting sequences  appear  to be responsible  for 
regulating transcription of  this gene in enterocytes and endo- 
crine cells. 
Functional mapping studies of the L-FABP gene allowed 
us to determine that different portions of its 5' nontranscribed 
region will direct different patterns of reporter  expression 
within a given enteroendocrine cell population. In some in- 
stances, these differences appear to be related to the region 
of  the intestine where the enteroendocrine cell subpopulation 
is located. For example, in transgenic pedigrees containing 
the L-FABP  -596 '° ÷2~/hGH transgene, the hGH reporter was 
coexpressed in most or all (70-100 %) GLP-1, CCK, secretin, 
and GIP-immunoreactive cells situated in the small intestine. 
A similar degree of coexpression was found for GLP-1, PP, 
and NPY immunoreactive cells located in the proximal co- 
lon. Although these latter two types of enteroendocrine cells 
are also present  in the distal  colon,  few contained  hGH. 
There  was also region-dependent  coexpression of hGH in 
serotonin producing enteroendocrine cells: in the duodenum 
and proximal jejunum ~10-30 % of  the serotonin immunore- 
active cells contained  hGH but the percent coIocalization 
declined sharply along the length of the intestine with virtu- 
ally no overlap present in the ileum and colon. Thus, analysis 
of these pedigrees of transgenic mice indicate that for the 
GLP-1, PP, NPY, and serotonin producing enteroendocrine 
cell populations, cis-acting sequences present between nu- 
cleotides  -596 and +21 of the rat L-FABP gene are suffi- 
cient to restrict hGH expression in some regions of  the intes- 
tine but not in others. This transgene thus subdivides these 
once apparently homogeneous enteroendocrine cell types (as 
defined by their neuroendocrine product) into subsets (now 
defined by their ability to support reporter  expression). 
A further level of complexity was revealed when we noted 
that addition of  nucleotides -597 to -4,000 of  the rat L-FABP 
gene affected expression of hGH in some, but not all,  en- 
teroendocrine cells. For example, its cis-acting elements did 
not alter the percentage of serotonin or GIP immunoreactive 
cells that synthesized hGH. They did, however, limit hGH 
expression to a smaller proportion of GLP-1, CCK, and se- 
cretin containing cells in the small intestine. Different degrees 
of restriction  of hGH expression were documented  within 
different regions of  the small intestine. These upstream DNA 
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GLP-1 cells slightly (from 100% to 70%) while in the prox- 
imal colon the percent colocalization of hGH and GLP-1 de- 
creased from nearly 100% to essentially zero. A similar prox- 
imal-to-distal axis-dependent decrease in colocalization of 
CCK and hGH  was also found within the small intestine. 
While the addition of nucleotides -4,000 to -597 produced 
some marked differences in the expression of hGH within 
certain enteroendocrine subsets located in different regions 
of the proximal to distal axis of the gut, they did not alter 
reporter  expression along the crypt-to-villus axis. 
Overall, our analyses of hGH expression in these entero- 
endocrine cell populations have uncovered subtle differences 
in expression of the two types of L-FABP/hGH transgenes. 
This allows us  to define three  subsets  of enteroendocrine 
cells based on the ability of nucleotides -597 to -4,000 to 
restrict hGH expression: (a) those ceils unaffected by the ad- 
ditional cis-acting elements (GIP and serotonin);  (b) those 
enteroendocrine cells showing a reduction in transgene  ex- 
pression independent of their location in the proximal-to- 
distal axis of the intestine (secretin, NPY, and PP) and (c) 
those ceils in which transgene expression is dependent upon 
their location along the duodenal-to-colonic axis (CCK and 
GLP-1). 
In  summary,  expression of L-FABP/hGH  transgenes  in 
different mouse enteroendocrine cell populations has revealed 
a heterogeneity in their regulatory environments which had 
not been previously appreciated. The results confirm that the 
5' nontranscribed region of the rat L-FABP gene is a sensitive 
indicator of these differences (5), differences that could re- 
flect regional and cell-specific variations  in the levels of as 
yet undefined  positive or negative trans-acting  factors. The 
data  emphasize that transgenes  represent powerful probes 
not only for examining the relationships between enteroen- 
docrine cell subsets (1), but also for analyzing the molecular 
mechanisms that establish and maintain the enormously com- 
plex patterns  of cellular differentiation in the continuously 
proliferating intestinal epithelium. 
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